BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 26055920)

  • 21. Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).
    Hauben M; Aronson JK; Ferner RE
    Drug Saf; 2016 May; 39(5):421-32. PubMed ID: 26879560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
    Trifirò G; Coloma PM; Rijnbeek PR; Romio S; Mosseveld B; Weibel D; Bonhoeffer J; Schuemie M; van der Lei J; Sturkenboom M
    J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion of National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM).
    You SC; Lee S; Cho SY; Park H; Jung S; Cho J; Yoon D; Park RW
    Stud Health Technol Inform; 2017; 245():467-470. PubMed ID: 29295138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model.
    Makadia R; Ryan PB
    EGEMS (Wash DC); 2014; 2(1):1110. PubMed ID: 25848597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of Mapping Austrian Health Claims Data to the OMOP Common Data Model.
    Haberson A; Rinner C; Schöberl A; Gall W
    J Med Syst; 2019 Sep; 43(10):314. PubMed ID: 31494719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation of Electronic Health Records and Questionnaire Data to OMOP CDM: A Feasibility Study Using SG_T2DM Dataset.
    Sathappan SMK; Jeon YS; Dang TK; Lim SC; Shao YM; Tai ES; Feng M
    Appl Clin Inform; 2021 Aug; 12(4):757-767. PubMed ID: 34380168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond.
    Papez V; Moinat M; Voss EA; Bazakou S; Van Winzum A; Peviani A; Payralbe S; Kallfelz M; Asselbergs FW; Prieto-Alhambra D; Dobson RJB; Denaxas S
    J Am Med Inform Assoc; 2022 Dec; 30(1):103-111. PubMed ID: 36227072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of Pathology Reports Into the Common Data Model With Oncology Module: Use Case for Colon Cancer.
    Ryu B; Yoon E; Kim S; Lee S; Baek H; Yi S; Na HY; Kim JW; Baek RM; Hwang H; Yoo S
    J Med Internet Res; 2020 Dec; 22(12):e18526. PubMed ID: 33295294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association.
    Gruber S; Chakravarty A; Heckbert SR; Levenson M; Martin D; Nelson JC; Psaty BM; Pinheiro S; Reich CG; Toh S; Walker AM
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):973-81. PubMed ID: 27418432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing performance of sequential analysis methods for active drug safety surveillance using observational data.
    Zhou X; Bao W; Gaffney M; Shen R; Young S; Bate A
    J Biopharm Stat; 2018; 28(4):668-681. PubMed ID: 29157113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transformation and Evaluation of the MIMIC Database in the OMOP Common Data Model: Development and Usability Study.
    Paris N; Lamer A; Parrot A
    JMIR Med Inform; 2021 Dec; 9(12):e30970. PubMed ID: 34904958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conceptual design of a generic data harmonization process for OMOP common data model.
    Henke E; Zoch M; Peng Y; Reinecke I; Sedlmayr M; Bathelt F
    BMC Med Inform Decis Mak; 2024 Feb; 24(1):58. PubMed ID: 38408983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.
    Schuemie MJ; Gini R; Coloma PM; Straatman H; Herings RM; Pedersen L; Innocenti F; Mazzaglia G; Picelli G; van der Lei J; Sturkenboom MC
    Drug Saf; 2013 Oct; 36 Suppl 1():S159-69. PubMed ID: 24166232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the Use of German Claims Data Vocabularies for Research in the Observational Medical Outcomes Partnership Common Data Model: Development and Evaluation Study.
    Henke E; Zoch M; Kallfelz M; Ruhnke T; Leutner LA; Spoden M; Günster C; Sedlmayr M; Bathelt F
    JMIR Med Inform; 2023 Nov; 11():e47959. PubMed ID: 37942786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incrementally Transforming Electronic Medical Records into the Observational Medical Outcomes Partnership Common Data Model: A Multidimensional Quality Assurance Approach.
    Lynch KE; Deppen SA; DuVall SL; Viernes B; Cao A; Park D; Hanchrow E; Hewa K; Greaves P; Matheny ME
    Appl Clin Inform; 2019 Oct; 10(5):794-803. PubMed ID: 31645076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating common data models for use with a longitudinal community registry.
    Garza M; Del Fiol G; Tenenbaum J; Walden A; Zozus MN
    J Biomed Inform; 2016 Dec; 64():333-341. PubMed ID: 27989817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.
    Baker MA; Nguyen M; Cole DV; Lee GM; Lieu TA
    Vaccine; 2013 Dec; 31 Suppl 10():K98-112. PubMed ID: 24331080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned.
    Carnahan RM; Moores KG
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():82-9. PubMed ID: 22262596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.
    Ryan PB; Madigan D; Stang PE; Overhage JM; Racoosin JA; Hartzema AG
    Stat Med; 2012 Dec; 31(30):4401-15. PubMed ID: 23015364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE Strategies.
    Gini R; Schuemie M; Brown J; Ryan P; Vacchi E; Coppola M; Cazzola W; Coloma P; Berni R; Diallo G; Oliveira JL; Avillach P; Trifirò G; Rijnbeek P; Bellentani M; van Der Lei J; Klazinga N; Sturkenboom M
    EGEMS (Wash DC); 2016; 4(1):1189. PubMed ID: 27014709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.